BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Inflammatory disorder
,
Heart
,
Personalized medicine
,
Aspirin
,
rs2300478
,
PTEN
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
ATTCTTT_MIR186
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Vagina
Kidney
Cervix
Myometrium
Urethra
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Pyloric ulcer
Smoker
Multiple-resistant Staphylococcus aureus infection
Barrett's esophagus
Microbial culture finding
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
JM 3100
CGP 60474
Glesatinib
GSK-1059615
triptolide
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
MIR122
POLH
NOP2
CRKL
DROSHA
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Breast epithelial D492 line with epithelial mesenchymal transition (EMT) after endothelial coculture
PBMC miRNA expression of tuberculosis, latent infected, and healthy subjects
Melanoma Cancer miRNA Blood Profiles
HPV cervical carcinogenesis microRNA expression
microRNA expression in cells resistant to endocrine therapy or in LTED breast cancer cell lines
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for ATTCTTT_MIR186
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
There were no clinical trials for ATTCTTT_MIR186
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ